NDC 82511-001 – Capecitabine
Capecitabine 150 mg/1 · Tablet, Film Coated · Oral
Product NDC82511-001
Product details
- Brand name
- Capecitabine
- Generic name
- Capecitabine
- Labeler
- Teyro Labs Private Limited
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA217237
- Marketed since
- February 16, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Capecitabine 150 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 82511-001-15 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82511-001-15) | Sep 1, 2022 |
Other Capecitabine products
- 16729-072 Capecitabine 150 mg/1 · Tablet, Film Coated · Accord Healthcare Inc.
- 16729-073 Capecitabine 500 mg/1 · Tablet, Film Coated · Accord Healthcare Inc.
- 60687-149 Capecitabine 500 mg/1 · Tablet, Film Coated · American Health Packaging
- 67877-459 Capecitabine 500 mg/1 · Tablet, Film Coated · Ascend Laboratories, LLC
- 67877-458 Capecitabine 150 mg/1 · Tablet, Film Coated · Ascend Laboratories, LLC
- 68001-487 Capecitabine 150 mg/1 · Tablet, Film Coated · BluePoint Laboratories
- 68001-644 Capecitabine 500 mg/1 · Tablet, Film Coated · BluePoint Laboratories
- 68001-643 Capecitabine 150 mg/1 · Tablet, Film Coated · BluePoint Laboratories
- 68001-488 Capecitabine 500 mg/1 · Tablet, Film Coated · BluePoint Laboratories
- 31722-774 Capecitabine 150 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-775 Capecitabine 500 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 69097-948 Capecitabine 500 mg/1 · Tablet, Film Coated · Cipla USA Inc.